Signal: LimmaTech raises $37m for antimicrobial resistance research
Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on Monday (9 October) that it has raised $37m in a…
Limmatech, the GSK spinout focusing on antimicrobial resistance, announced on Monday (9 October) that it has raised $37m in a…
A research study led by European Molecular Biology Laboratory (EMBL) has revealed that the effectiveness of antibiotics is altered when…